|
gptkbp:instanceOf
|
dissociative drug
cough suppressant
|
|
gptkbp:abbreviation
|
gptkb:dextromethorphan
|
|
gptkbp:abusePotential
|
yes
|
|
gptkbp:ATCCode
|
R05DA09
|
|
gptkbp:brand
|
gptkb:Coricidin
gptkb:Delsym
gptkb:NyQuil
gptkb:Robitussin
gptkb:Vicks_44
gptkb:Benylin
|
|
gptkbp:broadcastOn
|
unscheduled (US)
|
|
gptkbp:CASNumber
|
125-71-3
|
|
gptkbp:chemicalClass
|
gptkb:dextromethorphan
|
|
gptkbp:chemicalFormula
|
C18H25NO
|
|
gptkbp:contraindication
|
MAOI use
serotonin syndrome risk
|
|
gptkbp:developedBy
|
gptkb:Roche
|
|
gptkbp:discoveredIn
|
1953
|
|
gptkbp:eliminationHalfLife
|
2-4 hours
|
|
gptkbp:excretion
|
urine
|
|
gptkbp:foundIn
|
over-the-counter cough medicines
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
DXM
|
|
gptkbp:legalStatus
|
legal in most countries
|
|
gptkbp:mechanismOfAction
|
NMDA receptor antagonist
sigma-1 receptor agonist
|
|
gptkbp:metabolism
|
gptkb:dextrorphan
liver
|
|
gptkbp:molecularWeight
|
271.4 g/mol
|
|
gptkbp:overdoseSymptoms
|
yes
|
|
gptkbp:pregnancyCategory
|
C (US)
|
|
gptkbp:PubChem_CID
|
5360515
|
|
gptkbp:routeOfAdministration
|
oral
intramuscular
intravenous
sublingual
rectal
|
|
gptkbp:sideEffect
|
nausea
vomiting
itching
dissociation
drowsiness
tachycardia
hallucinations
|
|
gptkbp:UNII
|
7355X3RO96
|
|
gptkbp:usedFor
|
recreational drug
cough suppression
|
|
gptkbp:bfsParent
|
gptkb:Smart_Eye
|
|
gptkbp:bfsLayer
|
6
|